Opioid Use, Dependency, and Treatment in Pregnancy
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is pleased to present this Opioid Use Disorders and Treatment in Pregnancy webinar. The webinar will feature three national experts on the issue who will discuss how opioid use disorders are treated in pregnancy, its impact on infants and innovative strategies in working families. Hendrée Jones, PhD, Professor, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina (UNC), Chapel Hill and Executive Director, Horizons, co-author of the MOTHERS study. Dr. Jones will discuss the treatment of opioid use disorders during pregnancy and her work with women at UNC Horizons. Horizons is a program of the Department of Obstetrics and Gynecology at the UNC, Chapel Hill. The program provides substance abuse treatment for pregnant and parenting women and their children and works collaboratively with multiple service providers to provide a range of services. Carl Seashore, MD, Medical Director of the Newborn Nursery at UNC Chapel Hill, North Carolina Women's Hospital - Dr. Seashore will discuss the impact of prenatal exposure to opioids and share his experience in working with exposed infants in the Newborn period and with the Horizons program. Anne Johnston, MD, Associate Professor of Pediatrics, University of Vermont College of Medicine, Burlington, VT and Medical Director, Neonatal Medical Follow-Up Program, the University of Vermont Children's Hospital, Burlington, VT. Dr. Johnston also serves as the attending neonatologist at the University of Vermont Children's Hospital where she is a member of the CHARM collaborative, a group that provides care to infants prenatally exposed to opioids and their mothers. Dr. Johnston will highlight the features and services available to families through the CHARM collaborative following hospital discharge.
- Anne Johnston, MD
- Hendrée E. Jones, PhD
- Carl Seashore, MD
Date: May 13, 2015